Samsung Medical Center Opens Proton Therapy Facility
|
By HospiMedica International staff writers Posted on 13 Jun 2016 |
|
Image: The opening of the SMC proton therapy facility (Photo courtesy of SMC).
Samsung Medical Center (SMC; Seoul, South Korea) has opened a new proton therapy facility for cancer treatment, equipped with a cyclotron and two rotating gantries.
The SMC proton therapy facility will provide two different irradiation nozzle systems, including a multi-purpose nozzle in the first treatment room that can offer both conventional broad beam irradiation and advanced pencil beam scanning (PBS); irradiation modes can be switched on demand, depending on the target diseases. The second treatment room provides a dedicated scanning nozzle that offers PBS for larger fields (maximum 40x30 cm). A future, third treatment room is planned with a rotating gantry.
PBS delivers narrow proton beams to the targeted cancer tissue conforming to the shape of tumor, enabling complex tumors to be irradiated precisely with concentrated high doses, while minimizing side effects for surrounding healthy tissues. In comparison with broad beam irradiation, preparation prior to treatment is easier, and the consumable cost for patient’s specific compensators and collimators can be decreased by PBS. The broad beam treatment room (G1) opened in December 2015, and the large field PBS treatment room (G2) was launched in March 2016.
“Proton therapy is a state of the art radiation therapy which can increase the cure rate, while minimizing the normal tissue toxicity,” said Professor Youngyih Han, PhD, project manager of the SMC proton project. “Therefore, facilities introducing proton therapy have been ramped up all over the world and the demand is expected to grow. On the other hand, further technical research and development and professional human resource development for proton therapy is essential.”
SMC is one of the leading hospitals in Korea, with almost 2,000 patient beds, a staff of 8,000, and over 150,000 patients treated annually. It is composed of Samsung Seoul Hospital Kangbook Samsung Hospital, Samsung Changwon hospital, and the Samsung Life Sciences Research Center. SMC was founded in 1994 under the philosophy of “contributing to improving the nation’s health through the best medical service, advanced medical research, and development of outstanding medical personnel.”
Related Links:
Samsung Medical Center
The SMC proton therapy facility will provide two different irradiation nozzle systems, including a multi-purpose nozzle in the first treatment room that can offer both conventional broad beam irradiation and advanced pencil beam scanning (PBS); irradiation modes can be switched on demand, depending on the target diseases. The second treatment room provides a dedicated scanning nozzle that offers PBS for larger fields (maximum 40x30 cm). A future, third treatment room is planned with a rotating gantry.
PBS delivers narrow proton beams to the targeted cancer tissue conforming to the shape of tumor, enabling complex tumors to be irradiated precisely with concentrated high doses, while minimizing side effects for surrounding healthy tissues. In comparison with broad beam irradiation, preparation prior to treatment is easier, and the consumable cost for patient’s specific compensators and collimators can be decreased by PBS. The broad beam treatment room (G1) opened in December 2015, and the large field PBS treatment room (G2) was launched in March 2016.
“Proton therapy is a state of the art radiation therapy which can increase the cure rate, while minimizing the normal tissue toxicity,” said Professor Youngyih Han, PhD, project manager of the SMC proton project. “Therefore, facilities introducing proton therapy have been ramped up all over the world and the demand is expected to grow. On the other hand, further technical research and development and professional human resource development for proton therapy is essential.”
SMC is one of the leading hospitals in Korea, with almost 2,000 patient beds, a staff of 8,000, and over 150,000 patients treated annually. It is composed of Samsung Seoul Hospital Kangbook Samsung Hospital, Samsung Changwon hospital, and the Samsung Life Sciences Research Center. SMC was founded in 1994 under the philosophy of “contributing to improving the nation’s health through the best medical service, advanced medical research, and development of outstanding medical personnel.”
Related Links:
Samsung Medical Center
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Glucose Meter
StatStrip®
New
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Latest Hospital News News
- Nurse Tracking System Improves Hospital Workflow
- New Children’s Hospital Transforms California Healthcare
- Noisy Hospitals Face Threat of Decreased Federal Compensation
- Orthopedics Centre of Excellence Planned for Guy’s Hospital
- Research Suggests Avoidance of Low-Value Surgical Procedures
- U.S. Federal Readmission Fines Linked to Higher Mortality
- Columbia China to Build New Hospital in Jiaxing
- Dubai Debuts Second Robotic Pharmacy Service
- Seattle Hospital Network Shifts Away from Overlapping Surgeries
- ACC to Launch Valvular Heart Disease Program in China
- Mortality Rates Lower at Major Teaching Hospitals
- South Australia to Inaugurate Upscale Hospital
- Raffles to Launch Second Hospital Project in China
- Research Center Tackles Antimicrobial Drugs Challenge
- Miami Cardiac & Vascular Institute Completes Expansion Project
- Hospital Antibiotic Policies Improve Prescription Practices
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
